Pre-Training Reversible Inactivation of the Basal Amygdala (BA) Disrupts Contextual, but Not Auditory, Fear Conditioning, in Rats

PLoS One. 2015 Apr 30;10(4):e0125489. doi: 10.1371/journal.pone.0125489. eCollection 2015.

Abstract

The basolateral amygdala complex (BLA), including the lateral (LA), basal (BA) and accessory basal (AB) nuclei, is involved in acquisition of contextual and auditory fear conditioning. The BA is one of the main targets for hippocampal information, a brain structure critical for contextual learning, which integrates several discrete stimuli into a single configural representation. Congruent with the hodology, selective neurotoxic damage to the BA results in impairments in contextual, but not auditory, fear conditioning, similarly to the behavioral impairments found after hippocampal damage. This study evaluated the effects of muscimol-induced reversible inactivation of the BA during a simultaneous contextual and auditory fear conditioning training on later fear responses to both the context and the tone, tested separately, without muscimol administration. As compared to control rats micro-infused with vehicle, subjects micro-infused with muscimol before training exhibited, during testing without muscimol, significant reduction of freezing responses to the conditioned context, but not to the conditioned tone. Therefore, reversible inactivation of the BA during training impaired contextual, but not auditory fear conditioning, thus confirming and extending similar behavioral observations following selective neurotoxic damage to the BA and, in addition, revealing that this effect is not related to the lack of a functional BA during testing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Basolateral Nuclear Complex / drug effects
  • Basolateral Nuclear Complex / physiology*
  • Conditioning, Classical / drug effects
  • Conditioning, Classical / physiology*
  • Fear / drug effects
  • Fear / physiology*
  • Ketamine / pharmacology
  • Male
  • Rats
  • Rats, Wistar
  • Xylazine / pharmacology

Substances

  • Xylazine
  • Ketamine

Grants and funding

This study was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (2011/04820-7) http://www.fapesp.br/, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) http://www.capes.gov.br/ and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.